461/553US=57-B / Biol/Mol
Weinberg RA. Maintenance of genomic integrity and the development of cancer. In: ___. The biology of cancer. New York: Garland Science, 2007. p. 463-526. ISBN 0-8153-4078-8.

GENOMA; DESENVOLVIMENTO DO CANCER; SIMETRICAS DA CELULA-TRONCO. DIVISOES; ASSIMETRICAS DE CELULAS-TRONCO. DIVISOES; DIFERENCIACAO HEMATOPOETICA; DNA-POLIMERASES; MUTACOES DO GENE P53; AGENTES MUTAGENICOS; AFLATOXINA; FIGADO CARCINOGENESE; AMINA HETEROCICLICA; SINDROME MIELODISPLASICA; XERODERMA PIGMENTOSO

462/553US=57-B / Biol/Mol
Weinberg RA. Dialogue replaces monologue: heterotypic interactions and the biology of angiogenesis. In: ___. The biology of cancer. New York: Garland Science, 2007. p. 527-86. ISBN 0-8153-4078-8.

INTERACOES HETEROTIPICOS; BIOLOGIA DA ANGIOGENESE; LINFOMA DE HODGKIN; NEOPLASIAS DE CELULAS RARAS; TUMORES; PERICITOS

463/553US=57-B / Biol/Mol
Weinberg RA. Moving out: invasion and metastasis. In: ___. The biology of cancer. New York: Garland Science, 2007. p. 587-654. ISBN 0-8153-4078-8.

TUMOR DISSEMINADO; CITOQUERATINA; TRANSICAO EPITELIAL-MESENQUIMAL; E-CADERINA; CELULAS DE MELANOMA

464/553US=57-B / Biol/Mol
Weinberg RA. Crowd control: tumor immunology and immunotherapy. In: ___. The biology of cancer. New York: Garland Science, 2007. p. 655-724. ISBN 0-8153-4078-8.

IMUNOLOGIA DE TUMORES; IMUNOTERAPIA; MOLECULAS DE ANTICORPO POR NEUTRALIZACAO; LINFOCITOS T CITOTOXICOS; IMUNES ANTI-TUMORAIS, ESENVOLVIMENTO DE RESPOSTAS

465/553US=57-B / Biol/Mol
Weinberg RA. The rational treatment of cancer. In: ___. The biology of cancer. New York: Garland Science, 2007. p. 725-96. ISBN 0-8153-4078-8.

TRATAMENTO DE CANCER RACIONAL; GRANDES LINFOMAS DE CELULAS B; INIBIDORES DO CRESCIMENTO DE TUMORES; INIBIDORES DE INTERACOES PROTEINA-PROTEINA; KINOME HUMANO; ESTRUTURA SEMELHANTE DE QUINASES; TUMORES ESTROMAIS GASTROINTESTINAIS

466/553US=8 / Ginecologia
Vertrees RA, Jordan JM, Zwischenberger JB. Hyperthermia and chemotherapy: the science. In: Helm CW. Intraperitoneal cancer therapy. New Jersey: Humana Press, 2007. p. 71-100. ISBN 978-1-58829-878-2.

HIPERTERMIA E QUIMIOTERAPIA; CANCER; NEOPLASIA; METASTASE; QUIMIOTERAPIA HIPERTERMIA

467/553US=1-B / Farmacologia
Oates JA. The science of drug therapy. In: Brunton LL, Parker KL, Lazo JS. Goodman e Gilman's: the pharmacological basis of therapeutics. 11st ed. New York: McGraw-Hill, 2006. p. 117-36. ISBN 978-0-071-142280-3.

TERAPIA MEDICAMENTOSA; INTERACCOES FARMACODINAMICAS; FARMACODINAMICA; VARIABILIDADE FARMACODINAMICA; INDICE TERAPEUTICO; MONITORIZACAO TERAPEUTICA; BASE DE INFORMACAO DINAMICA; DROGA NOMENCLATURA

468/553US=2 / Biol/Mol
Gülow K, Kaminski M, Krammer PH. Death receptor: the role of CD95/CD95 ligand signaling in apoptosis and cancer. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 3-30. ISBN 978-3-527-31237-5.

RECEPTOR MORTE; SISTEMA CD95; SISTEMA CD95L; SINALIZACAO DA APOPTOSE; CANCER; MAQUINARIA APOPTOTICA; VIA INTRINSECA; VIA EXTRINSECA; MITOCONDRIAS; MECANISMOS DE RESISTENCIA; ANGIOGENESE

469/553US=2 / Biol/Mol
Walczak H, Koschny R, Willen D, Schader MB, Sykora J, Ganten TM, Haas TL. Death receptor: the TRAIL receptor-ligand system: biochemistry of apoptosis induction, therapeutic potential for cancer treatment and physiological function. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 31-92. ISBN 978-3-527-31237-5.

RECEPTOR MORTE; SISTEMA DE RECEPTOR-LIGANTE TRAIL; BIOQUIMICA DA INDUCAO DE APOPTOSE; POTENCIAL TERAPEUTICO; CANCER. TERAPIA; FUNCAO FISIOLOGICA; ATIVACAO DA CASPASE; FAMILIA BCL-2; UBIQUITINA; TERAPIA GENETICA; INFECCAO VIRAL; IMUNOPATOLOGIAS; DOENCAS AUTO-IMUNES; TRANSPLANTE ALOGENICO DE CELULAS-TRONCO HEMATOPOETICAS

470/553US=2 / Biol/Mol
Wajant H. Death receptor: mechanisms of tumor necrosis factor-induced cell death. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 93-119. ISBN 978-3-527-31237-5.

RECEPTOR DE MORTE; MORTE CELULAR; FATOR DE NECROSE TUMORAL; APOPTOSE; CANCER. TERAPIA

471/553US=2 / Biol/Mol
Micheau O. Death receptor: cellular FLICE-inhibitory protein: an update. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 120-56. ISBN 978-3-527-31237-5.

CANCER; RECEPTOR MORTE; PROTEINA INIBITORIA DA FLICE; GENE FLIP

472/553US=2 / Biol/Mol
Mehlen P, Lourenço FC. Death receptor: dependence receptors and apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 157-82. ISBN 978-3-527-31237-5.

RECEPTOR DE MORTE; RECEPTORES DE DEPENDENCIA; APOPTOSE; INTEGRINA; TIROSINA QUINASE

473/553US=2 / Biol/Mol
Saelens X, Festjens N, Walle LV, Vandenabeele P. Mitochondria: role of mitochondrial proteins in apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 183-221. ISBN 978-3-527-31237-5.

APOPTOSE; PAPEL DAS PROTEINAS MITOCONDRIAIS; FAMILIA BCL-2; PERMEABILIZACAO DA MEMBRANA MITOCONDRIAL; MUTACOES APOPTOTICAS; CITOCROMO C

474/553US=2 / Biol/Mol
Suzuki Y, Takahashi R. Mitochondria: omi/HtrA2: a mitochondrial serine protease regulating cellular life and death. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 222-32. ISBN 978-3-527-31237-5.

MITOCONDRIAS; OMI/HTRA2; SERINA PROTEASE MITOCONDRIAL; MORTE CELULAR

475/553US=2 / Biol/Mol
Vahsen N, Kroemer G. Mitochondria: apoptosis-inducing factor. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 233-55. ISBN 978-3-527-31237-5.

MITOCONDRIAS; FATOR DE INDUCAO DE APOPTOSE; ISOFORMES

476/553US=2 / Biol/Mol
Adrain C, Martin SJ. Effector systems: caspases: agents of defense and destruction. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 259-81. ISBN 978-3-527-31237-5.

SISTEMAS EFETORES; CASPASES; APOPTOSE

477/553US=2 / Biol/Mol
Cain K. Effector systems: the role of the apoptosome and cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 282-313. ISBN 978-3-527-31237-5.

SISTEMAS EFETORES; TERAPIA APOPTOSSOMO; CANCER; CITOCROMO C; CASPASE

478/553US=2 / Biol/Mol
Naik E, Strasser A. Bcl-2 family: the role of the Bcl-2 protein family in tumorigenesis and cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 317-45. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; TUMORIGENESE; CANCER. TERAPIA; MORTE CELULAR; APOPTOSE

479/553US=2 / Biol/Mol
Dempsey CE, Roberts DL, Dive C. Bcl-2 family: bax, bak and bid: key mediators of apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 346-78. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; BAX; BAK; BID; MEDIADORES DE APOPTOSE; VIAS MITOCONDRIAIS; CANCER

480/553US=2 / Biol/Mol
Erlacher M, Michalak EM, Strasser A, Villunger A. Bcl-2 family: the BH3-only proteins puma and noxa: two brothers in arms. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 379-402. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; PROTEINAS BH3; PUMA; NOXA; REGULACAO DA P53; MORTE CELULAR

Primeira | Anterior | Próxima | Última